Immune responses and protective efficacy induced by 85B antigen and early secreted antigenic target-6 kDa antigen fusion protein secreted by recombinant bacille Calmette-Guérin

Acta Biochimica et Biophysica Sinica

Volumn 39, Issue 4, 2007, Pages 290-296

  Shi, Changhong ^a   Wang, Xiaowu ^a   Zhang, Hai ^a   Xu, Zhikai ^a   Li, Yuan ^a   Yuan, Lintian ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Ag85B; BCG; ESAT6; Mycobacterium tuberculosis; Vaccine

Indexed keywords

ACYLTRANSFERASE; ANTIGEN 85B, MYCOBACTERIUM TUBERCULOSIS; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; BCG VACCINE; ESAT 6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; ESAT-6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; HYBRID PROTEIN; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; COMPARATIVE STUDY; CYTOLOGY; FEMALE; GENETICS; IMMUNIZATION; IMMUNOLOGY; METHODOLOGY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; SPLEEN; TUBERCULOSIS;

ACYLTRANSFERASES; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BCG VACCINE; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; RECOMBINANT FUSION PROTEINS; SPLEEN; TUBERCULOSIS;

MUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 34247238755     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1111/j.1745-7270.2007.00281.x     Document Type: Article

References (20)

1. Harries AD, Dye C. Tuberculosis. Ann Trop Med Parasitol 2006, 100: 415-431
2. Dhar N, Rao V, Tyagi AK. Skewing of the Th1/Th2 responses in mice due to variation in the level of expression of an antigen in a recombinant BCG system. Immunol Lett 2003, 88: 175-184
3. Palendira U, Spratt JM, Britton WJ, Triccas JA. Expanding the antigenic repertoire of BCG improves protective efficacy against aerosol Mycobacterium tuberculosis infection. Vaccine 2005, 23: 1680-1685
4. Pym AS, Brodin P, Majlessi L, Brosch R, Demangel C, Williams A, Griffiths KE et al. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med 2003, 9: 533-539
5. Hess J, Miko D, Catic A, Lehmensiek V, Russell DG, Kaufmann SH. Mycobacterium bovis bacille Calmette-Guérin strains secreting listeriolysin of Listeria monocytogenes. Proc Natl Acad Sci USA 1998, 95: 299-304
6. Luo Y, Chen X, Szilvasi A, O'Donnell MA. Co-expression of interleukin-2 and green fluorescent protein reporter in mycobacteria: In vivo application for monitoring antimycobacterial immunity. Mol Immunol 2000, 37: 527-536
7. Horwitz MA, Harth G, Dillon BJ, Masleša-Galić S. Recombinant bacillus Calmette-Guérin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci USA 2000, 97: 13853-13858
8. Fan XL, Yu TH, Gao Q, Yao W. Immunological properties of recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing fusion protein IL-2-ESAT-6. Acta Biochim Biophys Sin 2006, 38: 683-690
9. Weinrich Olsen A, van Pinxteren LA, Meng Okkels L, Birk Rasmussen P, Andersen P. Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6. Infect Immun 2001, 69: 2773-2778
10. Bao L, Chen W, Zhang H, Wang X. Virulence, immunogenicity, and protective efficacy of two recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing the antigen ESAT-6 from Mycobacterium tuberculosis. Infect Immun 2003, 71: 1656-1661
11. Fine PE. Variation in protection by BCG: Implications of and for heterologous immunity. Lancet 1995, 346: 1339-1345
12. Rao V, Dhar N, Tyagi AK. Modulation of host immune responses by overexpression of immunodominant antigens of Mycobacterium tuberculosis in bacille Calmette-Guérin. Scand J Immunol 2003, 58: 449-461
13. Yadav D, Khuller GK. Evaluation of immune responses directed against 30kDa secretory protein of Mycobacterium tuberculosis H37Ra complexed in different adjuvants. Indian J Exp Biol 2001, 39: 1227-1234
14. Carrara S, Vincenti D, Petrosillo N, Amicosante M, Girardi E, Goletti D. Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis 2004, 38: 754-756
15. Morris S, Kelley C, Howard A, Li Z, Collins F. The immunogenicity of single and combination DNA vaccines against tuberculosis. Vaccine 2000, 18: 2155-2163
16. Dietrich J, Aagaard C, Leah R, Olsen AW, Stryhn A, Doherty TM et al. Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: Efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy. J Immunol 2005, 174: 6332-6339
17. Murray PJ, Aldovini A, Young RA. Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines. Proc Natl Acad Sci USA 1996, 93: 934-939
18. Biet F, Kremer L, Wolowczuk I, Delacre M, Locht C. Mycobacterium bovis BCG producing interleukin-18 increases antigen-specific gamma interferon production in mice. Infect Immun 2002, 70: 6549-6557
19. Olsen AW, Hansen PR, Holm A, Andersen P. Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. Eur J Immunol 2000, 30: 1724-1732
20. Pym AS, Brodin P, Brosch R, Huerre M, Cole ST. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol Microbiology 2002, 46: 709-717